News & Updates

In the treatment of patients with rheumatoid arthritis (RA) and atherosclerotic cardiovascular disease (ASCVD), the use of tofacitinib confers an increased risk of major adverse cardiovascular events (MACE) than tumour necrosis factor inhibitors (TNFi), according to a post hoc analysis of ORAL Surveillance.

The use of multiple-dose antibiotic to prevent surgical site infection and implant removal following implant-based breast reconstruction does not appear to be more effective than a single-dose regimen, as shown in a study. In addition, the multi-dose regimen increases the risk of adverse events associated with antibiotic treatment.

A soft, miniaturized bioresorbable implant that delivers focused, minimally invasive cooling power in living tissues can help alleviate pain on demand without the use of medications and may provide an alternative to opioids and other highly addictive painkillers.

In locally advanced rectal cancer patients on neoadjuvant chemoradiation, a tumour volume threshold of 37.3 cm3 is associated with pathologic complete response (pCR), suggests a recent study.

Active surveillance (AS) along with timely delayed intervention (DI) is a safe and economical alternative to immediate intervention in patients with small renal masses (SRM), suggests a study.

Interrupting antithrombotic therapy among patients undergoing colonoscopy appears to contribute to higher thromboembolism (TE) events and even mortality, especially in high-risk patients, according to a study.